Financial reports
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
10-Q
2023 Q1
Quarterly report
5 May 23
ARS
2022 FY
Annual report to shareholders
20 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
Current reports
8-K
Other Events
8 Apr 24
8-K
Ocugen Provides Business Update with Certain Financials for the Year Ending 2023
2 Apr 24
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
1 Apr 24
8-K
Regulation FD Disclosure
21 Mar 24
8-K
Departure of Directors or Certain Officers
20 Mar 24
8-K
Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer
18 Mar 24
8-K
Regulation FD Disclosure
21 Feb 24
8-K
Departure of Directors or Certain Officers
8 Jan 24
8-K
Other Events
22 Dec 23
8-K
Other Events
9 Nov 23
Registration and prospectus
S-3
Shelf registration
17 Apr 24
424B5
Prospectus supplement for primary offering
25 May 23
424B5
Prospectus supplement for primary offering
23 May 23
S-8
Registration of securities for employees
28 Feb 23
S-8
Registration of securities for employees
28 Feb 23
POS AM
Prospectus update (post-effective amendment)
28 Feb 23
POSASR
Automatic shelf registration (post-effective amendment)
28 Feb 23
424B5
Prospectus supplement for primary offering
10 Jun 22
S-8
Registration of securities for employees
28 Feb 22
S-8
Registration of securities for employees
28 Feb 22
Proxies
DEFA14A
Additional proxy soliciting materials
21 Jun 23
DEFA14A
Additional proxy soliciting materials
20 Jun 23
DEFA14A
Additional proxy soliciting materials
9 Jun 23
DEFA14A
Additional proxy soliciting materials
30 May 23
DEFA14A
Additional proxy soliciting materials
24 May 23
DEFA14A
Additional proxy soliciting materials
22 May 23
DEFA14A
Additional proxy soliciting materials
17 May 23
DEFA14A
Additional proxy soliciting materials
15 May 23
DEFA14A
Additional proxy soliciting materials
11 May 23
DEFA14A
Additional proxy soliciting materials
8 May 23
Other
UPLOAD
Letter from SEC
12 Oct 23
CORRESP
Correspondence with SEC
4 Oct 23
UPLOAD
Letter from SEC
19 Sep 23
EFFECT
Notice of effectiveness
24 Apr 23
EFFECT
Notice of effectiveness
6 May 20
CORRESP
Correspondence with SEC
4 May 20
UPLOAD
Letter from SEC
6 Apr 20
SEC STAFF
SEC staff action: Order
19 Feb 20
SEC STAFF
SEC staff action: Order
6 Feb 20
EFFECT
Notice of effectiveness
6 Nov 19